Search Within

Anna Maria Litvak

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (6)
  2. Department of Pathology and Laboratory Medicine (6)
  3. GSK Faculty (6)
  4. Human Oncology and Pathogenesis Program (6)
  5. Solid Tumor Oncology Division (6)
  6. Thoracic Oncology (6)

More Groups

People
  1. Charles Rudin (5)
  2. Marc Ladanyi (5)
  3. Maria Pietanza (4)
  4. Mark Kris (4)
  5. Natasha Rekhtman (4)
  6. Gregory Riely (3)

More People

Years
  1. 2019 (2)
  2. 2016 (2)
  3. 2014 (2)
Publications
  1. Annals of Oncology (1)
  2. Clinical Cancer Research (1)
  3. Cold Spring Harbor Molecular Case Studies (1)
  4. Journal of Thoracic Oncology (1)
  5. Lung Cancer (1)
  6. Modern Pathology (1)
Publishers
  1. American Association for Cancer Research (1)
  2. Cold Spring Harbor Laboratory Press (1)
  3. Elsevier Inc. (1)
  4. Elsevier Ireland Ltd. (1)
  5. Nature Research (1)
  6. Oxford University Press (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Stage IV lung carcinoids: Spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices
    Journal Article

    Rekhtman, N.; Desmeules, P.; Litvak, A. M.; Pietanza, M. C.; Santos-Zabala, M. L.; Ni, A.; Montecalvo, J.; Chang, J. C.; Beras, A.; Preeshagul, I. R.; more...
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Exceptional responders with invasive mucinous adenocarcinomas: A phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
    Journal Article

    Drilon, A.; Schoenfeld, A. J.; Arbour, K. C.; Litvak, A.; Ni, A.; Montecalvo, J.; Yu, H. A.; Panora, E.; Ahn, L.; Kennedy, M.; more...
    Cold Spring Harbor Molecular Case Studies (2019)

    Fulltext@MSK | Save
  • A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
    Journal Article

    Pietanza, M. C.; Litvak, A. M.; Varghese, A. M.; Krug, L. M.; Fleisher, M.; Teitcher, J. B.; Holodny, A. I.; Sima, C. S.; Woo, K. M.; Ng, K. K.; more...
    Lung Cancer (2016)

    Fulltext@MSK | Save
  • Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets
    Journal Article

    Rekhtman, N.; Pietanza, M. C.; Hellmann, M. D.; Naidoo, J.; Arora, A.; Won, H.; Halpenny, D. F.; Wang, H.; Tian, S. K.; Litvak, A. M.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis program (MAP) at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Krug, L. M.; Pietanza, M. C.; Varghese, A. M.; Won, H.; Wang, L.; Rekhtman, N.; Travis, W. D.; Litvak, A.; Paik, P. K.; Riely, G. J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Clinical characteristics and course of 63 patients with BRAF mutant lung cancers
    Journal Article

    Litvak, A. M.; Paik, P. K.; Woo, K. M.; Sima, C. S.; Hellmann, M. D.; Arcila, M. E.; Ladanyi, M.; Rudin, C. M.; Kris, M. G.; Riely, G. J.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save